Methods and compositions to treat enteropathic arthritis

A method of treating enteropathic arthritis in a subject in need thereof, comprising:

• administering to the subject an effective amount of a pharmaceutical composition, wherein the pharmaceutical composition consists of:
• a) about 220 mg to about 880 mg of naproxen sodium, and about 60 mg to about 180 mg fexofenadine;
• and
• b) optionally, a pharmaceutical carrier, a pharmaceutical excipient, a sweetening agent, a flavoring agent, a taste masking ingredient, a diluent, alum, a stabilizer, a buffer, a coloring agent, a breath neutralizer, an emulsifying agent, a suspending agent, and combinations thereof,
• wherein the enteropathic arthritis is treated.

A pharmaceutical composition consisting of:

• a) an NSAID, and/or a salt thereof;
• b) a co-agent selected from the group consisting of:
• fexofenadine, ketotifen, desloratadine, cetirizine salts thereof and combinations thereof;
• and c) optionally, a pharmaceutical carrier, a pharmaceutical excipient, a sweetening agent, a flavoring agent, a taste masking ingredient, a diluent, alum, a stabilizer, a buffer, a coloring agent, a breath neutralizer, an emulsifying agent, a suspending agent, and combinations thereof.